China Resources Boya Bio-pharmaceutical Group Co.,Ltd Stock
Stocks
300294
CNE100001FF1
Pharmaceuticals
|
End-of-day quote
Shenzhen S.E.
2026-11-10
|
5-day change | 1st Jan Change | ||
| 13.93 CNY | -0.64% |
|
-1.49% | -38.36% |
| Market Cap | 7.02B 1.05B 943M 869M 789M 1.49B 98.56B 1.54B 10.4B 4.14B 52.81B 3.95B 3.86B 167B | P/E 2026 * |
15.6x | P/E 2027 * | 20.5x |
|---|---|---|---|---|---|
| Enterprise Value | 7.02B 1.05B 943M 869M 789M 1.49B 98.56B 1.54B 10.4B 4.14B 52.81B 3.95B 3.86B 167B | EV / Sales 2026 * |
3.74x | EV / Sales 2027 * | 3.53x |
| Free-Float |
16.25% | Yield 2026 * |
1.72% | Yield 2027 * | - |
| 1 day | -0.64% | ||
| 1 week | -1.49% | ||
| Current month | +2.20% | ||
| 1 month | -6.38% | ||
| 3 months | -11.56% | ||
| 6 months | -21.43% | ||
| Current year | -38.36% |
| 1 week | 13.93 |  | 14.4 |
| 1 month | 13.44 | | 14.97 |
| Current year | 13.44 | | 23.99 |
| 1 year | 13.44 | | 25.64 |
| 3 years | 13.44 | | 41.98 |
| 5 years | 13.44 | | 43.6 |
| 10 years | 13.44 | | 58.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yu Xuan Pan
DFI | Director of Finance/CFO | 42 | 2025-05-15 |
Hua Cheng Liang
DFI | Director of Finance/CFO | 44 | 2021-12-09 |
Dong Ke Peng
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gui Ling Tan
BRD | Director/Board Member | 59 | 2015-01-13 |
Hua Cheng Liang
BRD | Director/Board Member | 44 | 2021-12-26 |
Wei Dong Zhang
BRD | Director/Board Member | 63 | 2021-02-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/7/21 | Buy | Chief Executive Officer | 10,000 | 0.0023% | ||
| 3/18/21 | Buy | 71,300 | 0.0165% | |||
| 3/18/21 | Buy | Executive/Senior Manager | 47,400 | 0.0109% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.64% | -1.49% | -45.33% | -55.51% | 1.05B | |
| +1.44% | +1.63% | +48.17% | +139.63% | 1,276B | |
| -0.47% | +5.49% | +49.03% | +90.68% | 676B | |
| +0.20% | +2.76% | +34.37% | +112.06% | 519B | |
| -0.83% | +0.58% | +37.93% | +66.79% | 388B | |
| -0.48% | +2.34% | +70.66% | +46.02% | 365B | |
| -0.91% | -0.80% | +27.96% | +57.39% | 307B | |
| -0.13% | -1.06% | +3.04% | +35.40% | 287B | |
| 0.00% | +0.86% | +43.74% | +74.04% | 252B | |
| +0.92% | +2.03% | +44.62% | +125.07% | 212B | |
| Average | -0.27% | +1.86% | +31.42% | +69.16% | 428B | |
| Weighted average by Cap. | -0.33% | +2.51% | +42.69% | +96.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.88B 281M 252M 232M 211M 399M 26.37B 411M 2.78B 1.11B 14.13B 1.06B 1.03B 44.66B | 1.99B 298M 267M 246M 223M 423M 27.91B 435M 2.95B 1.17B 14.95B 1.12B 1.09B 47.27B |
| Net income | 304M 45.5M 40.8M 37.6M 34.15M 64.63M 4.27B 66.43M 450M 179M 2.29B 171M 167M 7.22B | 345M 51.63M 46.3M 42.67M 38.76M 73.35M 4.84B 75.39M 511M 204M 2.59B 194M 190M 8.2B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-10 | CN¥13.93 | -0.64% | 2,706,400 |
| 26-11-09 | CN¥14.02 | -1.61% | 3,263,728 |
| 26-11-06 | CN¥14.25 | -1.04% | 4,027,667 |
| 26-11-05 | CN¥14.40 | +0.84% | 3,867,580 |
| 26-11-04 | CN¥14.28 | +0.99% | 5,354,250 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 300294 Stock
Select your edition
All financial news and data tailored to specific country editions
